India approves Biological E. COVID shot as a booster

The Drugs Controller General of India (DCGI) gave the nod for the Corbevax vaccine to be administerd


Reuters June 05, 2022
A girl receives a dose of Biological E's COVID-19 vaccine, Corbevax, during a vaccination drive for children aged 12 to 14 inside a school in Ahmedabad, India, March 16, 2022. REUTERS

India has approved Hyderabad-based drugmaker Biological E's COVID-19 vaccine as the first mix-and-match booster dose in the country, the company said on Saturday.

The Drugs Controller General of India (DCGI) gave the nod for the Corbevax vaccine to be administerd as a booster shot to people age 18 years and over who have already received two doses of either AstraZeneca Plc's (AZN.L) Covishield or Bharat Biotech's Covaxin.

COMMENTS

Replying to X

Comments are moderated and generally will be posted if they are on-topic and not abusive.

For more information, please see our Comments FAQ